EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Purinergic signal transduction and metabolic regulation by ENTPD5 and ENTPD6

Yihang Qi, Xuefei Li, Xinyu Song, Wenyi Wei, Ionita Ghiran, Simon C Robson

Frontiers in Endocrinology · 28.01.2026 · 17

DOI: 10.3389/fendo.2026.1680378 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Endocrinology, online erschienen am 28.01.2026. Verfasst von Yihang Qi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Inflammation Research, Department of Anesthesia, Critical Care & Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical Scho…. Hauptthemen laut MEDLINE: Signal Transduction, Apyrase, Neoplasms, Purines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ENTPD5 and ENTPD6 are members of the CD39-ectonucleoside triphosphate diphosphohydrolase (CD39-ENTPD) family, which play an important role in modulating the purinergic signaling pathway. Most of the knowledge in this area has been obtained by studying CD39/ENTPD1, the prototype member of this family, and evaluating the translational potential by either treating inflammation directly with recombinant proteins or by using antagonists to elicit immune responses in cancer. ENTPD5 and ENTPD6, “orphan-type” ectonucleotidases, are understudied to date, although both are expressed at high levels in various tissues, where they appear involved in regulating signal transduction, cellular energy, and metabolism. ENTPD5 is abnormally overexpressed in several types of malignancies, including prostate, liver, lung, and ovarian cancers. ENTPD5 appears to promote protein glycosylation and folding in part by regulating UDP and UMP levels, thereby enhancing the survival and proliferation of somatic or cancer cells. As such, ENTPD5 has been considered a potential proto-oncogene and a therapeutic target in cancer treatment. In contrast, despite comparable functionality, the related ENTPD6 shows relatively stable expression across tissues in both normal and pathological conditions, with specific roles in cancer yet unclear. This review provides a comprehensive overview of these two understudied ectoenzymes, detailing their shared molecular structures and control of purinergic signal transduction. In addition, we explore different patterns of tissue and organelle expression of these ecto-enzymes and propose relevance to the modulation of cellular metabolism, as would be important in cancer. We review the sometimes conflicting evidence from experimental animal models and propose potential future clinical applications. This review offers insights into the roles of this distinct duo of ENTPD family members to support future basic and translational research in this field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Signal TransductionApyraseNeoplasmsPurinesHumansAnimalsProto-Oncogene MasPyrophosphatasesOncogene Proteins

Stichwörter der Autor:innen

CD39L2CD39L4ENTPD5ENTPD6cancerectonucleoside triphosphate diphosphohydrolase 5ectonucleoside triphosphate diphosphohydrolase 6purinergic signaling pathway

Substanzen

ENTPD5 protein, humanProto-Oncogene MasApyraseMAS1 protein, humanPurinesPyrophosphatasesOncogene Proteins

Autor:innen und Institutionen

  • Center for Inflammation Research, Department of Anesthesia, Critical Care & Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.
  • Department of Anesthesiology, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
  • Department of Medical Oncology, Qilu Hospital of Shandong University, Jinan, China.
  • Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.

Zitieren

APA

Qi, Y., Li, X., Song, X., Wei, W., Ghiran, I., & Robson, S. C. (2026). Purinergic signal transduction and metabolic regulation by ENTPD5 and ENTPD6. Frontiers in Endocrinology, 17. https://doi.org/10.3389/fendo.2026.1680378

Vancouver

Qi Y, Li X, Song X, Wei W, Ghiran I, Robson SC. Purinergic signal transduction and metabolic regulation by ENTPD5 and ENTPD6. Frontiers in Endocrinology. 2026;17. doi:10.3389/fendo.2026.1680378

BibTeX
@article{Qi2026,
  author = {Qi, Yihang and Li, Xuefei and Song, Xinyu and Wei, Wenyi and Ghiran, Ionita and Robson, Simon C},
  title = {Purinergic signal transduction and metabolic regulation by ENTPD5 and ENTPD6},
  journal = {Frontiers in Endocrinology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fendo.2026.1680378}
}
Kostenlos starten →